Opt-out screening is an approach where all patients are informed that HIV/STIs screening will be performed as part of routine medical care, unless the patient specifically declines. Included in the job aid are resources from various sources (including the CDC and CDPH), a workflow for a typical office visit, and guidelines for best practices.
Recent research has shown that opt-out guidelines increase screening rates and subsequent treatment for HIV and STIs (such as chlamydia, gonorrhea, and syphilis). This method reduces stigma, improves health equity, and opens the door for more comprehensive care.
Please join us for a morning half-day STI Intensive offered in-person and virtually at no cost at the University of California, San Francisco at the ZSFG campus. There will also be an in-person (only) afternoon wet-mount at the UCSF Parnassus campus available to a limited number of the morning-training participants at no cost. This event will cover topics including STI epidemiology, syphilis, mycoplasma genitalium, HPV, and biomedical STI prevention. Speakers will include faculty from CAPTC (UCSF), the San Francisco Department of Public Health, and the California Department of Public Health.
½ Day Didactic: Morning – Early Afternoon
Hybrid event being offered in-person at UCSF Pride Hall & Virtually by Zoom
Onsite breakfast and refreshments provided
CME will be offered at no cost
Topics will cover STI trends (national and California); biomedical STI prevention; syphilis cases; updates in STI management, with a focus on syphilis, mycoplasma genitalium and HPV.
Recording currently unavailable.
Wet Mount: Mid Afternoon-Evening
Previous microscopy skills are required to take this course. Registration prioritized for STI Intensive didactic attendees. Space limited to 12 max capacity.
In-person only training being offered at UCSF Parnassus Heights
3-hour laboratory course
CME will be offered at no cost
Topics will cover CLIA regulation, quality control, and interpretation vaginal wet mount (VWM) for common causes of vaginitis. Microscope footage of findings on VWM including trichomonads, yeast and clue cells associated with BV. Experiential training, including laboratory practicum on examination of saline and KOH vaginal wet mounts (VWM). Participants will have an opportunity for group discussion, explanation, and demonstration, as well as practice and return demonstration.
STI Clinical Update Webinar – Syphilis in Pregnancy
November 20, 2024 12:00PM-1:15PM (PST) 1.25 CME units at no cost
Presenters
Kathleen Jacobson, MD Chief, STD Control Branch, California Department of Public Health
Wyatt Hanft, MD, MPH STI Fellow, STD Control Branch, California Department of Public Health & California Prevention Training Center at UCSF
Course Description
Drs. Kathleen Jacobson and Wyatt Hanft will provide a 1-hour virtual training focused on syphilis clinical presentation, screening/testing, diagnosis, treatment, and follow-up for pregnant patients. The presenters will use a case-based format to help attendees apply the learned material to a real-life scenario.
Learning Objectives
Review the epidemiology of syphilis and congenital syphilis (CS) in California
Apply the American College of Obstetrics and Gynecology (ACOG) screening recommendations during pregnancy
Compare traditional and reverse screening algorithms for syphilis
Describe syphilis diagnosis, treatment and follow up during pregnancy
Calculating Interview Periods
A foundational step in any STI interview is determining the interview period. This timeframe is crucial for identifying sexual partners who may require testing and treatment. The DI Professional will calculate this period before the interview begins. The interview period represents the maximum possible duration during which the person could have contracted or transmitted the infection.
To equip DI Professionals with the knowledge and skills necessary to accurately calculate interview periods for persons diagnosed with STIs/HIV.
In this e-learning module learners will:
Define interview period and its importance in working with people who are diagnosed with an STI/HIV.
Discuss factors affecting interview period length (e.g., STI type, symptoms, risk behaviors).
Calculate Interview Periods for Specific STIs using different patient profiles and STI/HIV diagnoses(Primary, Secondary, and Early Latent syphilis, Chlamydia, Gonorrhea, PID, and HIV).
STI Clinical Update-Sacramento and Yolo Counties: Congenital Symposium
In-person only event
Monday, October 28, 2024 9:00AM-3:30PM (PDT) Sacramento, CA 5.00 CME units at no cost
Please note: This is an in-person only event onsite in Sacramento, CA. Registration is limited to local DIS and clinicians in the Sacramento and Yolo counties region. Registration closes on October 25th at 3:00PM (PDT).
Recognize common manifestations of primary and secondary syphilis, compare traditional and reverse screening algorithms, and determine appropriate syphilis staging, treatment, and follow-up.
Implement CDC recommendations for CS testing and treatment based on infant and birthing parent labs and exam at the time of delivery, and apply current CDPH syphilis screening guidelines to pregnant people in California.
Cite evidence supporting doxy-PEP use, understand CDPH recommendations for doxy-PEP prescribing, and counsel patients on potential risks/benefits and follow-up for this biomedical prevention method.
Cite local trend data illustrating increased rates of Congenital Syphilis and syphilis among women, as a rationale for enhanced clinical screening for STIs for people who may become pregnant and during pregnancy.
Identify at least two local approaches to congenital syphilis prevention, including how to obtain wrap-around services for pregnant people with syphilis, and resources provided via partnerships with local surveillance programs.
Presenters Dr. Wyatt Hanft STI Fellow, California Prevention Training Center & California Department of Public Health, STD Control Branch
Dr. Kurtis Mohr Public Health Medical Officer, California Department of Public Health, STD Control Branch
Prenatal Syphilis Screening, Staging, and Management for Congenital Syphilis Prevention
This pocket guide summarizes all the essentials of prenatal syphilis screening, staging, and management with the goal of preventing congenital syphilis.
Special Guest: Stefan Madzar, PrEP & HIV Benefits Coordinator & Linkage Navigator at Magnet (San Francisco AIDS Foundation).
Stefan will present an update on Magnet’s injectable PrEP program, including challenges, successes, and lessons learned, and featuring clients who will discuss their experiences taking injectable PrEP.
Special Guest: Stefan Madzar, PrEP & HIV Benefits Coordinator & Linkage Navigator at Magnet (San Francisco AIDS Foundation).
Stefan will present an update on Magnet’s injectable PrEP program, including challenges, successes, and lessons learned, and featuring clients who will discuss their experiences taking injectable PrEP.
Thursday, July 18, 12-1pm PDT
STI Clinical Update Webinar– Summer 2024 Update and Review: Syphilis, Chlamydia, and Gonorrhea, County of Lake
Presented by Drs. Kelly Johnson and Kurtis Mohr Wednesday, July 24, 2024 11:00AM – 1:00PM (PDT)
CME not available for viewing the webinar recording.
Learning Objectives
Describe the varied clinical manifestations of primary and secondary syphilis in adults and adolescents
Appropriately stage and treat syphilis in both pregnant and non-pregnant people
Recognize the different sequelae of sexually transmitted C. trachomatis and N. Gonorrhoeae infections & their recommended treatments
CAPTC is pleased to announce two job aids, focused on mpox recognition, diagnosis, testing, treatment, and vaccination.
The shorter job aid is called “Mpox Clinical Recognition and Testing Quicksheet: Mpox Presentations vs. Common Exanthems.” It is intended as a print resource, to help facilitate clinical recognition of mpox in health care settings. The longer job aid, “Mpox Clinical Recognition and Testing Overview,” is intended as an electronic resource. It has links to a number of helpful mpox-related resources.
We use cookies to ensure that we give you the best experience on our website, but we also recognize the right to privacy. Please accept or disable cookies for this website.
